Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexalin Technology (NXL) Return on Sales (2021 - 2025)

Nexalin Technology (NXL) has 5 years of Return on Sales data on record, last reported at 125.42% in Q3 2025.

  • For Q3 2025, Return on Sales fell 5747.0% year-over-year to 125.42%; the TTM value through Sep 2025 reached 55.3%, down 2100.0%, while the annual FY2024 figure was 45.12%, 314.0% down from the prior year.
  • Return on Sales reached 125.42% in Q3 2025 per NXL's latest filing, down from 22.4% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.54% in Q3 2022 and bottomed at 125.42% in Q3 2025.
  • Average Return on Sales over 5 years is 41.56%, with a median of 28.53% recorded in 2021.
  • Peak YoY movement for Return on Sales: soared 3203bps in 2022, then tumbled -9473bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 32.56% in 2021, then skyrocketed by 41bps to 19.08% in 2022, then crashed by -99bps to 38.01% in 2023, then crashed by -174bps to 104.25% in 2024, then decreased by -20bps to 125.42% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 125.42% in Q3 2025, 22.4% in Q2 2025, and 48.45% in Q1 2025.